List of Excipients in API cevimeline hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cevimeline hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Cosette Pharmaceuticals Inc | EVOXAC | cevimeline hydrochloride | 0713-0883 | HYDROXYPROPYL CELLULOSE | |
| Cosette Pharmaceuticals Inc | EVOXAC | cevimeline hydrochloride | 0713-0883 | LACTOSE MONOHYDRATE | |
| Cosette Pharmaceuticals Inc | EVOXAC | cevimeline hydrochloride | 0713-0883 | MAGNESIUM STEARATE | |
| Cosette Pharmaceuticals Inc | CEVIMELINE HYDROCHLORIDE | cevimeline hydrochloride | 0713-0937 | HYDROXYPROPYL CELLULOSE | |
| Cosette Pharmaceuticals Inc | CEVIMELINE HYDROCHLORIDE | cevimeline hydrochloride | 0713-0937 | LACTOSE MONOHYDRATE | |
| Cosette Pharmaceuticals Inc | CEVIMELINE HYDROCHLORIDE | cevimeline hydrochloride | 0713-0937 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing cevimeline hydrochloride
Detailed excipient profiles for cevimeline hydrochloride
Excipient focus: ALCOHOL
cevimeline hydrochloride drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cevimeline hydrochloride | 33342-216 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing ALCOHOL
Excipient focus: AMMONIA
cevimeline hydrochloride drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cevimeline hydrochloride | 33342-216 |
| Novel Laboratories Inc | cevimeline hydrochloride | 40032-999 |
| Lupin PharmaceuticalsInc | cevimeline hydrochloride | 43386-999 |
| Bionpharma Inc | cevimeline hydrochloride | 69452-316 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
cevimeline hydrochloride drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cevimeline hydrochloride | 33342-216 |
| Novel Laboratories Inc | cevimeline hydrochloride | 40032-999 |
| Lupin PharmaceuticalsInc | cevimeline hydrochloride | 43386-999 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing BUTYL ALCOHOL
Excipient focus: D&C YELLOW NO. 10
cevimeline hydrochloride drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | cevimeline hydrochloride | 40032-999 |
| Lupin PharmaceuticalsInc | cevimeline hydrochloride | 43386-999 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C RED NO. 40
cevimeline hydrochloride drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | cevimeline hydrochloride | 40032-999 |
| Lupin PharmaceuticalsInc | cevimeline hydrochloride | 43386-999 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
cevimeline hydrochloride drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | cevimeline hydrochloride | 40032-999 |
| Lupin PharmaceuticalsInc | cevimeline hydrochloride | 43386-999 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
cevimeline hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | cevimeline hydrochloride | 0054-0334 |
| Bryant Ranch Prepack | cevimeline hydrochloride | 71335-2264 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERROSOFERRIC OXIDE
cevimeline hydrochloride drug variants containing FERROSOFERRIC OXIDE
cevimeline hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
cevimeline hydrochloride drug variants containing GELATIN
cevimeline hydrochloride drug variants not containing GELATIN
Excipient focus: GLYCERIN
cevimeline hydrochloride drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | cevimeline hydrochloride | 0054-0334 |
| Bryant Ranch Prepack | cevimeline hydrochloride | 71335-2264 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing GLYCERIN
Excipient focus: HYDROXYPROPYL CELLULOSE
cevimeline hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
cevimeline hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
cevimeline hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cevimeline hydrochloride | 33342-216 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: ISOPROPYL ALCOHOL
cevimeline hydrochloride drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cevimeline hydrochloride | 33342-216 |
| Novel Laboratories Inc | cevimeline hydrochloride | 40032-999 |
| Lupin PharmaceuticalsInc | cevimeline hydrochloride | 43386-999 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
cevimeline hydrochloride drug variants containing LACTOSE MONOHYDRATE
cevimeline hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
cevimeline hydrochloride drug variants containing MAGNESIUM STEARATE
cevimeline hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
cevimeline hydrochloride drug variants containing POTASSIUM HYDROXIDE
cevimeline hydrochloride drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
cevimeline hydrochloride drug variants containing PROPYLENE GLYCOL
cevimeline hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
cevimeline hydrochloride drug variants containing SHELLAC
cevimeline hydrochloride drug variants not containing SHELLAC
Excipient focus: SODIUM LAURYL SULFATE
cevimeline hydrochloride drug variants containing SODIUM LAURYL SULFATE
cevimeline hydrochloride drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: TITANIUM DIOXIDE
cevimeline hydrochloride drug variants containing TITANIUM DIOXIDE
cevimeline hydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
cevimeline hydrochloride drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | cevimeline hydrochloride | 0054-0334 |
| Macleods Pharmaceuticals Limited | cevimeline hydrochloride | 33342-216 |
| Bryant Ranch Prepack | cevimeline hydrochloride | 71335-2264 |
| >Company | >Ingredient | >NDC |
cevimeline hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
